Literature DB >> 2583091

Phosphorylation of hepatic phenobarbital-inducible cytochrome P-450.

W Pyerin1, H Taniguchi.   

Abstract

The major phenobarbital-inducible cytochrome P-450 purified from rat liver, a member of family II of the cytochrome P-450 gene superfamily, is rapidly phosphorylated by cAMP-dependent protein kinase. The phosphorylation reaches greater than 0.5 mol phosphate/mol P-450 after 5 min and is accompanied by a decrease in enzyme activity. The serine residue in position 128 was shown to be the sole phosphorylation site and a conformational change of the protein was indicated by a shift of the carbon monoxide difference spectrum of the reduced cytochrome from 450 to 420 nm. Comparison of amino acid sequences of various cytochrome P-450 families revealed a highly conserved arginine residue in the immediate vicinity of the phosphorylated serine residue which constitutes the kinase recognition sequence. It also revealed that only the members of the cytochrome P-450 family II carry this kinase recognition sequence. To find out whether this phosphorylation also occurs in vivo, the exchangeable phosphate pool of intact hepatocytes derived from phenobarbital-pretreated rats was labeled with 32Pi followed by an incubation of the cells with the membrane-permeating dibutyryl-cAMP or with the adenylate cyclase stimulator glucagon to activate endogenous kinase. As a result, a microsomal polypeptide with the same electrophoretic mobility as cytochrome P-450 became strongly labeled. Peptide mapping and immunoprecipitation with monospecific antibodies identified this protein as the major phenobarbital-inducible cytochrome P-450. It becomes phosphorylated at the same serine residues as in the cell-free phosphorylation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2583091      PMCID: PMC401374          DOI: 10.1002/j.1460-2075.1989.tb08450.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  53 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  Effect of cyclic AMP on the phenobarbital induced increase in cytochrome P-450 and hypertrophy of the endoplasmic reticulum of the rat liver.

Authors:  F Hutterer; K Dressler; H Greim; P Czygan; F Schaffner; H Popper
Journal:  Adv Exp Med Biol       Date:  1975       Impact factor: 2.622

3.  Sex-dependent effects of cyclic AMP on the hepatic mixed function oxidase system.

Authors:  W E Ross; C Simrell; W W Oppelt
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1973-03

4.  Inhibition of hepatic drug metabolism by cyclic 3',5'-adenosine monophosphate.

Authors:  M Weiner; G G Buterbaugh; D A Blake
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1972-03

5.  Activation of protein kinase by physiological concentrations of cyclic AMP.

Authors:  J A Beavo; P J Bechtel; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

6.  Krebs EG: Purification and characterization of a protein inhibitor of adenosine 3',5'-monophosphate-dependent protein kinases.

Authors:  D A Walsh; C D Ashby; C Gonzalez; D Calkins; E H Fischer
Journal:  J Biol Chem       Date:  1971-04-10       Impact factor: 5.157

7.  Sex differences in the effects of abnormal physiological states on the metabolism of drugs by rat liver microsomes.

Authors:  R Kato; J R Gillette
Journal:  J Pharmacol Exp Ther       Date:  1965-11       Impact factor: 4.030

8.  A general method applicable to the search for similarities in the amino acid sequence of two proteins.

Authors:  S B Needleman; C D Wunsch
Journal:  J Mol Biol       Date:  1970-03       Impact factor: 5.469

9.  The complete amino acid sequence of a constitutive form of liver microsomal cytochrome P-450.

Authors:  J Ozols; F S Heinemann; E F Johnson
Journal:  J Biol Chem       Date:  1985-05-10       Impact factor: 5.157

10.  Studies on the mechanism of inhibition of drug biotransformation by cyclic adenine nucleotides.

Authors:  M Weiner; G G Buterbaugh; D A Blake
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1972-07
View more
  8 in total

Review 1.  Phenobarbital induction of cytochrome P-450 gene expression.

Authors:  D J Waxman; L Azaroff
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

Review 2.  Phosphorylation of cytochrome P450 isoenzymes in intact hepatocytes and its importance for their function in metabolic processes.

Authors:  B Oesch-Bartlomowicz; F Oesch
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

3.  Substrate-, hormone-, and cAMP-regulated cytochrome P450 degradation.

Authors:  E Eliasson; I Johansson; M Ingelman-Sundberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Ubiquitin-dependent proteasomal degradation of human liver cytochrome P450 2E1: identification of sites targeted for phosphorylation and ubiquitination.

Authors:  YongQiang Wang; Shenheng Guan; Poulomi Acharya; Dennis R Koop; Yi Liu; Mingxiang Liao; Alma L Burlingame; Maria Almira Correia
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

5.  Genetic analysis of aflatoxin B1 activation in rat hepatoma cells.

Authors:  L Corcos; J P Rousset; F Kiefer; F J Wiebel; M C Weiss
Journal:  Mol Gen Genet       Date:  1990-07

6.  A role for protein phosphorylation in cytochrome P450 3A4 ubiquitin-dependent proteasomal degradation.

Authors:  Yongqiang Wang; Mingxiang Liao; Nicholas Hoe; Poulomi Acharya; Changhui Deng; Andrew N Krutchinsky; Maria Almira Correia
Journal:  J Biol Chem       Date:  2008-12-18       Impact factor: 5.157

7.  Bimodal targeting of microsomal CYP2E1 to mitochondria through activation of an N-terminal chimeric signal by cAMP-mediated phosphorylation.

Authors:  Marie-Anne Robin; Hindupur K Anandatheerthavarada; Gopa Biswas; Naresh Babu V Sepuri; Donna M Gordon; Debkumar Pain; Narayan G Avadhani
Journal:  J Biol Chem       Date:  2002-08-20       Impact factor: 5.157

8.  Mechanism-based predictions of interactions.

Authors:  F Oesch; B Oesch-Bartlomowicz; J Arens; F Fähndrich; E Vogel; T Friedberg; H Glatt
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.